Variant report
Variant | nsv600041 |
---|---|
Chromosome Location | chr5:151508799-151518810 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:151509815..151512281-chr5:151517345..151519719,2 | MCF-7 | breast: | |
2 | chr5:151513919..151516215-chr5:151517657..151519224,2 | K562 | blood: | |
3 | chr5:151513919..151516215-chr5:151517657..151519224,2 | K562 | blood: | |
4 | chr5:151513671..151516215-chr5:151517705..151520059,3 | K562 | blood: | |
5 | chr5:151509815..151512281-chr5:151517345..151519719,2 | MCF-7 | breast: | |
6 | chr5:151513671..151516215-chr5:151517705..151520059,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs29837 | chr5:151508799-151508800 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs184092356 | chr5:151508825-151508826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572860894 | chr5:151508854-151508855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142726415 | chr5:151508905-151508906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565484837 | chr5:151508914-151508915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532828998 | chr5:151508949-151508950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12652437 | chr5:151508977-151508978 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs550926178 | chr5:151509010-151509011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563073728 | chr5:151509033-151509034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529833688 | chr5:151509034-151509035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188876867 | chr5:151509059-151509060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538456023 | chr5:151509089-151509090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556506753 | chr5:151509104-151509105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566480611 | chr5:151509118-151509119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533820081 | chr5:151509145-151509146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs28378200 | chr5:151509198-151509199 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs570690667 | chr5:151509202-151509203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114031209 | chr5:151509278-151509279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556107003 | chr5:151509287-151509288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574540654 | chr5:151509316-151509317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577752423 | chr5:151509443-151509444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs151242272 | chr5:151509492-151509493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543563293 | chr5:151509540-151509541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140430685 | chr5:151509541-151509542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115909946 | chr5:151509543-151509544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542398794 | chr5:151509584-151509585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150406638 | chr5:151509634-151509635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369568169 | chr5:151509646-151509647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs29836 | chr5:151509649-151509650 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs572876938 | chr5:151509665-151509666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75791115 | chr5:151509683-151509684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181582447 | chr5:151509718-151509719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530272545 | chr5:151509738-151509739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563359291 | chr5:151509762-151509763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186136311 | chr5:151509764-151509765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12657138 | chr5:151509781-151509782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs73274922 | chr5:151509801-151509802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs373325356 | chr5:151509803-151509804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114243705 | chr5:151509804-151509805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551915575 | chr5:151509813-151509814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528916666 | chr5:151509851-151509852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570399721 | chr5:151509868-151509869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs79685519 | chr5:151509928-151509929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565681816 | chr5:151509947-151509948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550009003 | chr5:151509949-151509950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567917507 | chr5:151509974-151509975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74420449 | chr5:151509986-151509987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553539998 | chr5:151510017-151510018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566656925 | chr5:151510026-151510027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534004400 | chr5:151510085-151510086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Parkinson disease | 21829596 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:151505600-151511600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:151511600-151512000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:151513800-151515000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
4 | chr5:151515000-151518200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
5 | chr5:151516000-151516800 | Enhancers | Fetal Lung | lung |
6 | chr5:151516200-151517200 | Enhancers | Brain Hippocampus Middle | brain |
7 | chr5:151516400-151518600 | Enhancers | Ovary | ovary |
8 | chr5:151516600-151516800 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:151516600-151516800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
10 | chr5:151516600-151518000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
11 | chr5:151517600-151518200 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr5:151518200-151518600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
13 | chr5:151518600-151531200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |